{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:07:55Z","timestamp":1789049275088,"version":"build-2803163510"},"reference-count":33,"publisher":"American Chemical Society (ACS)","issue":"17","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Abnormal N-methyl-d-aspartate receptor (NMDAr) function is implicated in schizophrenia and other neuropsychiatric disorders. Enhancing NMDAr signaling can be achieved by increasing synaptic d-serine levels through the inhibition of D-amino acid oxidase (DAAO). We report the synthesis and preclinical evaluation of [18F]2 ([18F]PGM028299), a novel PET radiotracer for imaging DAAO in the brain. Enzyme occupancy studies in rodents showed that [18F]2 is a displaceable ligand, with binding blocked dose dependently by the DAAO inhibitor luvadaxistat. Radiosynthesis was initially achieved via a copper-mediated radiofluorination. Subsequent optimization using a Sonogashira coupling strategy resulted in improved radiochemical yields. PET imaging studies demonstrated rapid brain uptake, with the highest retention observed in the cerebellum and brainstem, along with reversible tracer kinetics. Tracer kinetic modeling showed that specific binding was abolished following pharmacological challenge. Human dosimetry estimates indicated a favorable safety profile. These findings support [18F]2 as a promising PET tracer for in vivo DAAO imaging.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01035","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:01:42Z","timestamp":1786536102000},"page":"20761-20771","source":"Crossref","is-referenced-by-count":0,"title":["In Vivo Rodent\nStudies with the Novel PET Tracer [18F]PGM028299: An Inhibitor\nof D-Amino Acid Oxidase"],"prefix":"10.1021","volume":"69","author":[{"given":"Mayca","family":"Onega","sequence":"first","affiliation":[{"name":"Imanova Ltd., Now Dba Perceptive Discovery, Burlington Danes Building, Hammersmith Hospital , Du Cane Road , ,","place":["London, U.K., W12 0NN"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eimear","family":"Howley","sequence":"additional","affiliation":[{"name":"Takeda Cambridge Ltd. , 418 Cambridge Science Park, Milton Road , , ,","place":["Cambridge, Cambridgeshire, U.K., CB4 0PA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Fieldhouse","sequence":"additional","affiliation":[{"name":"Takeda Cambridge Ltd. , 418 Cambridge Science Park, Milton Road , , ,","place":["Cambridge, Cambridgeshire, U.K., CB4 0PA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Almond","sequence":"additional","affiliation":[{"name":"Takeda Cambridge Ltd. , 418 Cambridge Science Park, Milton Road , , ,","place":["Cambridge, Cambridgeshire, U.K., CB4 0PA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Farnaby","sequence":"additional","affiliation":[{"name":"Takeda Cambridge Ltd. , 418 Cambridge Science Park, Milton Road , , ,","place":["Cambridge, Cambridgeshire, U.K., CB4 0PA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrina","family":"Kerr","sequence":"additional","affiliation":[{"name":"Takeda Cambridge Ltd. , 418 Cambridge Science Park, Milton Road , , ,","place":["Cambridge, Cambridgeshire, U.K., CB4 0PA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Takeda Cambridge Ltd. , 418 Cambridge Science Park, Milton Road , , ,","place":["Cambridge, Cambridgeshire, U.K., CB4 0PA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Fradley","sequence":"additional","affiliation":[{"name":"Takeda Cambridge Ltd. , 418 Cambridge Science Park, Milton Road , , ,","place":["Cambridge, Cambridgeshire, U.K., CB4 0PA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshal","family":"Patel","sequence":"additional","affiliation":[{"name":"Takeda Cambridge Ltd. , 418 Cambridge Science Park, Milton Road , , ,","place":["Cambridge, Cambridgeshire, U.K., CB4 0PA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4222-7858","authenticated-orcid":true,"given":"Matt","family":"Barnes","sequence":"additional","affiliation":[{"name":"Takeda Cambridge Ltd. , 418 Cambridge Science Park, Milton Road , , ,","place":["Cambridge, Cambridgeshire, U.K., CB4 0PA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Coello","sequence":"additional","affiliation":[{"name":"Imanova Ltd., Now Dba Perceptive Discovery, Burlington Danes Building, Hammersmith Hospital , Du Cane Road , ,","place":["London, U.K., W12 0NN"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger N","family":"Gunn","sequence":"additional","affiliation":[{"name":"Imanova Ltd., Now Dba Perceptive Discovery, Burlington Danes Building, Hammersmith Hospital , Du Cane Road , ,","place":["London, U.K., W12 0NN"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Keat","sequence":"additional","affiliation":[{"name":"Hammersmith Hospital , , Du Cane Road , ,","place":["London, U.K., W12 0NN"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Ashworth","sequence":"additional","affiliation":[{"name":"Hammersmith Hospital , , Du Cane Road , ,","place":["London, U.K., W12 0NN"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sac-Pham","family":"Tang","sequence":"additional","affiliation":[{"name":"Hammersmith Hospital , , Du Cane Road , ,","place":["London, U.K., W12 0NN"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A","family":"Wells","sequence":"additional","affiliation":[{"name":"Hammersmith Hospital , , Du Cane Road , ,","place":["London, U.K., W12 0NN"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenii A","family":"Rabiner","sequence":"additional","affiliation":[{"name":"Hammersmith Hospital , , Du Cane Road , ,","place":["London, U.K., W12 0NN"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Passchier","sequence":"additional","affiliation":[{"name":"Imanova Ltd., Now Dba Perceptive Discovery, Burlington Danes Building, Hammersmith Hospital , Du Cane Road , ,","place":["London, U.K., W12 0NN"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Tauscher","sequence":"additional","affiliation":[{"name":"Takeda Development Center Americas, Inc. , One Takeda Parkway , , ,","place":["Deerfield, Illinois, United States, 60015"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Miller","sequence":"additional","affiliation":[{"name":"Takeda Cambridge Ltd. , 418 Cambridge Science Park, Milton Road , , ,","place":["Cambridge, Cambridgeshire, U.K., CB4 0PA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0688-1358","authenticated-orcid":true,"given":"Christophe","family":"Plisson","sequence":"additional","affiliation":[{"name":"Hammersmith Hospital , , Du Cane Road , ,","place":["London, U.K., W12 0NN"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"2026091009062299600_cit1","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/schbul\/sbs076","article-title":"NMDA Receptor\nand schizophrenia: A brief history","volume":"38","author":"Coyle","year":"2012","journal-title":"Schizophr.\nBull."},{"key":"2026091009062299600_cit2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1523\/JNEUROSCI.08-01-00185.1988","article-title":"Pharmacology of glutamate neurotoxicity\nin cortical cell culture: attenuation by NMDA antagonists","volume":"8","author":"Choi","year":"1988","journal-title":"J. Neurosci."},{"key":"2026091009062299600_cit3a","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nrd3893","article-title":"Glycine transporters\nas novel therapeutic\ntargets in schizophrenia, alcohol dependence and pain","volume":"12","author":"Harvey","year":"2013","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026091009062299600_cit3b","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/7355_2014_53","article-title":"GlyT1 inhibitors: From hits to clinical\ncandidates","volume":"13","author":"Porter","year":"2014","journal-title":"Top Med. Chem."},{"issue":"1","key":"2026091009062299600_cit4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biopsych.2016.11.014","article-title":"Bitopertin in Negative\nSymptoms of Schizophrenia-Results From the Phase III FlashLyte and\nDayLyte Studies","volume":"82","author":"Bugarski-Kirola","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"2026091009062299600_cit5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1046\/j.1471-4159.1995.65010454.x","article-title":"Functional comparison of D-serine and glycine in rodents: the effect\non cloned NMDA receptors and the extracellular concentration","volume":"65","author":"Matsui","year":"1995","journal-title":"J. Neurochem."},{"key":"2026091009062299600_cit6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor\nsubunit diversity:\nimpact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"2026091009062299600_cit7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cell.2012.06.029","article-title":"Synaptic and extrasynaptic NMDA receptors\nare gated by different endogenous coagonists","volume":"150","author":"Papouin","year":"2012","journal-title":"Cell"},{"key":"2026091009062299600_cit8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jpba.2018.09.026","article-title":"Pharmacokinetics and toxicokinetics of D-serine in\nrats","volume":"162","author":"Hasegawa","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"2026091009062299600_cit9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.schres.2010.05.012","article-title":"High dose D-serine\nin the treatment of schizophrenia","volume":"121","author":"Kantrowitz","year":"2010","journal-title":"Schizophr.\nRes."},{"key":"2026091009062299600_cit10","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1042\/bj0291620","article-title":"Metabolism\nof amino acids: deamination of amino acids","volume":"29","author":"Krebs","year":"1935","journal-title":"Biochem. J."},{"key":"2026091009062299600_cit11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/mp.2009.99","article-title":"The neurobiology\nof D-amino acid oxidase and its involvement in schizophrenia","volume":"15","author":"Verrall","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"2026091009062299600_cit12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.mcn.2006.05.003","article-title":"Behavioural and biochemical\ncharacterization of a mutant\nmouse lacking D-amino acid oxidase activity and its implications for\nschizophrenia","volume":"32","author":"Almond","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"2026091009062299600_cit13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3940(00)01658-X","article-title":"Exaggerated\nresponses to chronic\nnociceptive stimuli and enhancement of N-methyl-D-aspartate\nreceptor-mediated synaptic transmission in mutant mice lacking D-amino-acid\noxidase","volume":"297","author":"Wake","year":"2001","journal-title":"Neurosci. Lett."},{"key":"2026091009062299600_cit14","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1001\/jamapsychiatry.2013.2159","article-title":"Add-on treatment of benzoate for\nschizophrenia: a randomized,\ndouble-blind, placebo-controlled trial of D-amino acid oxidase inhibitor","volume":"70","author":"Lane","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"2026091009062299600_cit15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.biopsych.2013.08.010","article-title":"Benzoate,\na D-amino acid oxidase\ninhibitor, for the treatment of early phase Alzheimer\u2019s disease:\na randomised, double blind, placebo-controlled trial","volume":"75","author":"Lin","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"2026091009062299600_cit16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/bs.apha.2024.10.016","article-title":"Evolution\nof D-amino acid oxidase inhibitors: From\nconcept to clinic","volume":"102","author":"Bajaj","year":"2025","journal-title":"Adv. Pharmacol."},{"key":"2026091009062299600_cit17","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1007\/s11064-023-03956-2","article-title":"Luvadaxistat: A\nNovel Potent and Selective d-Amino Acid Oxidase Inhibitor Improves\nCognitive and Social Deficits in Rodent Models for Schizophrenia","volume":"48","author":"Fradley","year":"2023","journal-title":"Neurochem. Res."},{"key":"2026091009062299600_cit18a","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/0361-9230(87)90076-1","article-title":"Localisation of D-amino\nacid oxidase in Bergmann glial cells and astrocytes of rat cerebellum","volume":"19","author":"Horiike","year":"1987","journal-title":"Brain Res. Bull."},{"key":"2026091009062299600_cit18b","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0006-8993(94)90240-2","article-title":"D-Amino acid oxidase is confined to the lower brain stem and cerebellum\nin rat brain: regional differences in astrocytes","volume":"652","author":"Horiike","year":"1994","journal-title":"Brain Res."},{"key":"2026091009062299600_cit19","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/j.1460-9568.2007.05769.x","article-title":"D-Amino acid oxidase and serine racemase\nin human brain: normal distribution and altered expression in schizophrenia","volume":"26","author":"Verrall","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"2026091009062299600_cit20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s11065-010-9142-x","article-title":"The role\nof the cerebellum in cognition and emotion: Personal reflections since\n1982 on the dysmetria of thought hypothesis and its historical evolution\nfrom theory to therapy","volume":"20","author":"Schmahmann","year":"2010","journal-title":"Neuropsy Rev."},{"key":"2026091009062299600_cit21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1023\/A:1007064504007","article-title":"Immunocytochemical\nlocalization of d-amino acid oxidase in rat brain","volume":"28","author":"Moreno","year":"1999","journal-title":"J. Neurocytol."},{"key":"2026091009062299600_cit22","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.neuint.2011.08.017","article-title":"Levels of\nD-serine in the brain and\nperipheral organs of serine racemase (Srr) knock-out mice","volume":"59","author":"Horio","year":"2011","journal-title":"Neurochem. Int."},{"key":"2026091009062299600_cit23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.schres.2024.06.017","article-title":"INTERACT:\na randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults\nwith schizophrenia","volume":"270","author":"Murthy","year":"2024","journal-title":"Schizophr. Res."},{"key":"2026091009062299600_cit24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.drudis.2011.12.020","article-title":"Can the flow of medicines be improved?\nFundamental pharmacokinetic and pharmacological principles towards\nimproving phase II survival","volume":"17","author":"Morgan","year":"2012","journal-title":"Drug Discovery\nToday"},{"key":"2026091009062299600_cit25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of\nAstraZeneca\u2019s drug pipeline: a five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026091009062299600_cit26","doi-asserted-by":"publisher","first-page":"127326","DOI":"10.1016\/j.bmcl.2020.127326","article-title":"Synthesis\nand preliminary evaluation of 4-hydroxy-6-(3-[11C]methoxyphenethyl)pyridazin-3(2H)-one,\na 11C-labeled -amino acid oxidase (DAAO) inhibitor for PET imaging","volume":"30","author":"Deng","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026091009062299600_cit27","doi-asserted-by":"publisher","first-page":"16292","DOI":"10.1021\/ja408607r","article-title":"Cu(OTf)2-Mediated fluorination of aryltrifluoroborates\nwith potassium fluoride","volume":"135","author":"Ye","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"2026091009062299600_cit28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/jcbfm.2009.190","article-title":"Measuring\ndrug occupancy in the absence of a reference region: the Lassen plot\nre-visited","volume":"30","author":"Cunningham","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2026091009062299600_cit29","first-page":"1023","article-title":"OLINDA\/EXM:\nthe second-generation\npersonal computer software for internal dose assessment in nuclear\nmedicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J. Nucl. Med."},{"key":"2026091009062299600_cit30","volume-title":"1990 Recommendations of the International\nCommission on Radiological Protection.","author":"Pergamon Press.","year":"1991"},{"key":"2026091009062299600_cit31","unstructured":"Farnaby, W.; Fieldhouse, C.; Hazel, K.; Kerr, C.; Kinsella, N.; Livermore, D.; Merchant, K.; Miller, D..  Pyridazinone compounds and their use as\nDAAO inhibitors. US 9,931,340 B2. 2013."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01035","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/17\/20761\/66507873\/acs.jmedchem.6c01035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/17\/20761\/66507873\/acs.jmedchem.6c01035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:15:42Z","timestamp":1789046142000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/17\/20761\/5253249\/In-Vivo-Rodent-Studies-with-the-Novel-PET-Tracer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":33,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,8,12]]},"published-print":{"date-parts":[[2026,9,10]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01035","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}